Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug imports.

The proposal would see the HHS set price targets other countries pay for certain medicines, kicking off a round of discussions with substantial ramifications for drugmakers. It’s likely to be challenged in court,

President Donald Trump on Monday revived a plan to tie prescription drug prices in the U.S. to what other nations pay for medicines. The executive order, which was first reported by POLITICO, still leaves many questions about how the administration will implement a so-called “most-favored nation” policy.